acid; MiNP, mono-isononyl phthalate; Mn, manganese; mg/kg/day, milligram per kilogram per day; mg/m 3 , milligram per cubic meter; MnBP, mono-n-butyl phthalate; MOA, mode of action;
Introduction
The European Union's 7th Framework Programme (EU's FP7) project HEALS -Health and Environment-wide Associations based on Large Population Surveys -started in 2013 with a term of 5 years. The objective of HEALS is the refinement of an integrated methodology and the application of analytical and computational tools for elucidating human exposome through the integrated use of advanced statistical tools for environment-wide association studies (EWAS) in support of EU-wide environment and health assessments (www.heals-eu.eu).
Important determinants for the development of diseases are genetic influences and the interaction of environmental stressors (Schwartz and Collins, 2007) . Described with the complementary approach of nature and nurture, the term "environment" includes everything that is not genetic (Smith et al., 1999) . Consequently, the genome needs to be complemented by the exposome (Wild, 2005 (Wild, , 2012 . While the human "genome is fixed at conception" (but changed by mutagenic influences) (Rappaport, 2011) , "the exposome encompasses life-course environmental exposures […] , from the prenatal period onwards" (Wild, 2005) . Based on the above, genome-wide association studies (GWAS) attempt to describe the influence of genetic factors for the development of diseases (Hirschhorn and Daly, 2005) , while EWAS investigate the associations between a wide range of environmental factors and diseases (Patel et al., 2010) . In this context, human biomonitoring (HBM) -procedures to determine substances or biological markers in human specimens (Angerer et al., 2007 ) -provides a valuable tool for understanding the magnitude of exposure from all pathways and sources. A biomarker of exposure (BoE) "may be the identification of an exogenous substance within the system, the interactive product between a xenobiotic compound and endogenous components, or other event in the biological system related to the exposure" (NRC, 1987) . BoEs include either stressors themselves (e.g. the parent compounds), or their metabolites (reaction products), identified in a variety of human specimens such as blood, urine, deciduous teeth or hair (CDC, 2005) .
HEALS encompasses a more integrative approach for associating environmental exposures and disease mechanisms and outcomes. Data from the external environment, e.g., measurements of chemicals in different media (e.g. air, water, soil and food), are combined with data regarding internal exposure, e.g., measurements of chemicals in urine or blood, to build the exposome and to derive environment-wide associations between exposure and disease. Starting from HBM samples, quantification of exposure biomarkers, together with identification of markers of effect and susceptibility (mainly-omics), builds the analytical exposure biology framework for unraveling the human exposome using multi-omics technologies according to the HEALS paradigm.
To evaluate HBM data, reference and exposure limit values as well as biomonitoring equivalents are useful and receive particular attention in the HEALS project. Reference values describe the upper level of the populations' background concentration (Angerer et al., 2007; Schulz et al., 2011) . The HBM Commission of the German Environment Agency defines the reference value RV 95 as "the 95 population percentile […] rounded off within the 95% confidence interval" of the respective parameter in the matrix obtained from the reference population (Schulz et al., 2011) . Reference values contain no information about healthrelated biological exposure limits (Angerer et al., 2007) .
Popular health-related biological exposure limit values are the German HBM I and II values. There is no health risk assumable if the concentration of a substance in urine or blood is below the HBM I level.
A health risk cannot be excluded if the concentration of a substance in urine or blood is between HBM I and HBM II. An increased risk for adverse health effects is given if the concentration is above HBM II (Schulz et al., 2011) . Additional exposure limit values are used in the literature. Mocarelli et al. (1986) defined a cut-off limit for pathological results set at "eight times the SD [standard deviation] value above the mean". Critical concentrations (CC) define the concentration below which the probability of health effects is negligible as was it observed in children at birth (ANSES, 2013) . Specific exposure limit values are also mentioned. For example, the copper concentration indicating probable depletion resulting in health effects (Burtis et al., 2012) , the early morning cortisol concentration suggesting adrenal insufficiency, and cut-off points which distinguish tobacco use vs. no tobacco use (Kim, 2016) have been determined. The BAT (biological tolerance value) and BEI (biological exposure indices) values are occupational exposure limit values. BAT is the "concentration for a substance […] in the corresponding biological material at which the health of an employee generally is not adversely affected even when the person is repeatedly exposed during long periods" (DFG, 2016) . The BEI is the "level of the determinant most likely to be observed in specimens collected from a worker with an internal dose equivalent to that arising solely from inhalation exposure at the TLV [threshold limit value] concentration". The TLV represents a safe concentration in air in occupational contexts (Morgan, 1997) .
Besides reference values and exposure limit values, biomonitoring equivalents (BEs) are of importance, because they are a first screening method to evaluate potential risk from exposure to environmental stressors using HBM data. BEs are defined as the concentration of a chemical or metabolite in a biological matrix (blood, urine, human milk, etc.) , consistent with defined exposure guidance values or toxicity criteria. These include reference doses (RfD) and reference concentrations (RfC), minimal risk levels (MRL) and tolerable daily intakes (TDI), which have been defined using the knowledge available regarding the toxicokinetic properties of the chemical (Boogaard et al., 2011) . The application of BEs is based on the assumption that intake and excretion are at equilibrium. This ensures coherence between the guidance values for chronic exposure and the estimated BE (Angerer et al., 2011) . Use of reliable physiology-based biokinetic (PBBK) models is the most convenient way to translate external exposure reference values into BEs. Details on the methodology and the specific assumptions for the derivation of BEs for each compound can be found in the references given in Table 4 . In general, the main steps for deriving a BE are summarized below:
(I) The identification of the point of departure (POD) that was used for deriving the external exposure reference value (e.g., TDI or RfD). (II) If the POD has been derived from an animal study (which is the most common case), then the respective uncertainty factors that account for interspecies extrapolation and, if needed, the lowest observed adverse effect level (LOAEL) to no observed adverse effect level (NOAEL) extrapolation, are used to calculate the humanequivalent POD. (III) By using either a simple pharmacokinetic (PK) or more sophisticated PBBK model, we estimate the expected concentration at the matrix of interest, assuming an intake equal to the humanequivalent POD. For rapidly metabolized compounds, when a urinary metabolite is identified the daily urinary excretion of the compound normalized by average urine volume and average creatinine excretion at the daily exposure rate equal to the humanequivalent POD has to be estimated. For this we have to make an assumption on the percentage of intake that is eliminated via the urinary tract. In both cases, the result of the toxicokinetic calculation helps us to derive the biological matrix-related BE POD . (IV) Finally, to end up with a BE value that is relevant to humans, uncertainty factors related to intraspecies differences have to be applied on the BE POD . When a detailed PBTK model is available, intraspecies variability can be directly incorporated in the relevant anthropometric (i.e. bodyweight, body mass index) and biochemical (e.g. metabolic rates based on the genetic polymorphisms of the cytochrome P450 [CYP] isozymes) parameters.
For non-persistent compounds, such as phthalates and bisphenol A, BEs refer usually to levels of metabolite(s) measured in urine; for persistent compounds the biological matrix of reference is either milk (e.g. for POPs) or blood (e.g. heavy metals like Cd and Pb).
In the framework of HEALS, BoEs of a large number of environmental stressors were reviewed and used for supporting environmentwide associations. The main objective of this work was to summarize the availability of BoEs for the broad range of environmental stressors and exposure determinants of interest in HEALS (including heavy metals, persistent and non-persistent organic compounds, particulate matter and biologicals) and corresponding reference and exposure limit values and biomonitoring equivalents useful for unraveling the exposome using the EWAS framework. Additionally, environmental stressors and exposure determinants without known BoEs were discussed.
Methodology
This review was based on an expert panel discussion to determine scope, content, and structure of the HEALS guidelines for appropriate BoE selection for EWAS studies. An extensive list of the most important environmental stressor categories as well as selected stressors relevant to human health of the population in the EU was created based on expert opinion. An expert-driven, distributed, narrative review process involving around 30 scientists of the HEALS consortium made it possible to include extensive information targeted towards the specific characteristics of the individual stressor. A narrative/qualitative review design was preferred in contrast to a systematic one, because the intention was to give a broad comprehensive overview of the great number of topics included (Callcut and Branson, 2009; Cook et al., 1997) .
The review process was organized on the basis of stressor-specific fact sheets. Every author summarized the latest information about chemical properties, effects on biological systems, exposure routes, absorption, elimination, specimens for analysis, and eventually reference and exposure limit values for at least one (mostly more than one) fact sheet(s). There was no common systematic strategy for literature searches because of the diversity of topics. However, an internal review process (see below) reduced possible researcher bias during the literature search. While most fact sheets were created for specific environmental stressors (e.g., mercury), in some cases it was necessary to summarize a group of stressors in one fact sheet (e.g., psychological occupational hazards). This was an essential, yet feasible approach in some cases, so as to represent a wide range of stressors important to determine the exposome of the EU population.
Information was obtained from comprehensive reports of international organizations (e.g., WHO's Environmental Health Criteria) and other mainstream scientific literature supplemented by the latest research results published in PubMed listed journal papers. Overall, more than 800 references were reviewed.
For quality assurance, all contributors were involved in an internal review process. Each fact sheet was reviewed by at least two project partners, while one of them was the project coordinator, co-coordinator, or leader of the HEALS HBM work package. The leading question for the review process was: "Is the quality, content, and extent of the fact sheet as well as the literature selection suitable and is the information included up to date?" The literature review process described above resulted in a dedicated technical report available for download on the HEALS website: http://www.heals-eu.eu/wp-content/ uploads/2013/08/HEALS_D4.2.pdf. A concise selection of information was extracted, updated, and key conclusions are summarized in this 
Results
A total of 64 chemical, biological, physical, social, or psychological stressors organized in 13 broad stressor categories were selected (Table 1) to fulfil the requirements of EWAS, although the BoEs for some exposure determinants/modifiers (e.g., socioeconomic status) were not expected to be available. In total, information of 135 BoE is summarized. If available, reference values (Table 2) , exposure limit values (Table 3) , and biomonitoring equivalents (Table 4) are presented. From the complete list of individual stressors (Table 1) , 12 were identified without a BoE. These stressors (and some summarized groups of stressors like psychological occupational hazards) are included in Table 5 to discuss opportunities other than HBM to collect information about their internal exposure. Table 1 includes the stressor categories and stressors with available BoEs as well as -if available -an incomplete selection of corresponding reference values. Reference values were found for 104 of the 135 considered BoEs. Table 3 contains exposure limit values and Table 4 BEs by stressor, when available. Exposure limit values are available for 16 of the 130 considered BoEs. BEs are available for not more than 42 of the 130 BoEs considered.
Discussion
Specific BoEs are available for several environmental stressors but not for others. While chemicals and their primary metabolites may be measureable in human specimens, it is not possible at this time to identify BoEs for stressors such as electromagnetic fields or for exposure determinants/modifiers such as socioeconomic status using (Schoeters et al., 2016) (continued on next page) (Becker et al., 2008; Schulz et al., 2009; Schulz et al., 2011) (continued on next page) N. Steckling et al. Environmental Research 164 (2018) 597-624 (Wilhelm et al., 2004) Cr Cr blood RI: 0.7-28.0 µg/l Population (age not specified; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) 24-h urine Reference value(**): < 0.2 µg/l Population (age not specified; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) serum RI: 0.1-0.2 µg/l Population (age not specified; sample size not specified), country not specified serum RI: 70-140 µg/dl Men (age not specified; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) RI: 80-155 µg/dl Women (age not specified; sample size not specified), country not specified (continued on next page) Mn Mn blood RI: 5-15 µg/l (age not specified; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) serum RI: 0.5-1.3 µg/l (age not specified; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) urine (not further specified) RI: 0.5-9.8 µg/l (age not specified; sample size not specified), country not specified serum RI: 16-71 µg/l Children (< 2 years;; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) RI: 40-103 µg/l Children (2-4 years; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) RI: 55-134 µg/l Children (4-16 years; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) RI: 63-160 µg/l Adults (age not specified; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) Zn Zn 24-h urine P 5 -P 95 : 48.8-529 µg/l Students (age not specified; n: 126), Germany (Münster, Ulm) 2016 (UBA, 2017) (continued on next page) serum RI: 80-120 µg/dl Adults (age not specified; sample size not specified), country not specified Survey year not specified (Burtis et al., 2012) volatile organic compounds acrylamide AAMA urine (not further specified) urine (not further specified) MCT (mean, median, or GM): 0.5-9 µg/l Non-smoking general population (age not specified; sample size not specified), countries not specified (several cohorts) General population (18-83 years; n: 48), Cyprus (Nicosia) 2013 (Tsangari et al., 2017) (continued on next page) Reference value: < 1 µg/l (**) Non-smoker (age not specified; sample size not specified), country not specified Survey year not specified (Scholz, 2001b) spot urine P 95 : 481-1361 ng/l -1 , depending on the city Primary school children (age not specified; n: 107-147, depending on the city), Italy (Poggibonsi, Treviglio, Valenza) 1995 (Minoia et al., 1996) (continued on next page) NOC 12-h overnight urine Mean 1.12 µmol/l (Max:3.8 µmol/ l) Non-smoking healthy adults (age not specified; n: 12), France (Lyon) Survey year not specified (Pignatelli et al., 1989) (continued on next page) General population, no sprinters and no medium or long distance runners (age not specified, sample size not specified); country not specified Survey year not specified (Palacios et al., 2015) creatinine serum Concentration > 1.3 mg/dl Adult male athletes (age not specified, sample size not specified), country not specified Survey year not specified (Palacios et al., 2015) lactate blood Threshold at which lactate increases exponentially due to exercises: 4.0 mmol/L General population (age not specified, sample size not specified); country not specified Survey year not specified (Palacios et al., 2015) stress cortisol plasma Reference range: 138-690 nmol/l Adults (age not specified, sample size not specified); country not specified Survey year not specified (Zografos et al., 2010) saliva (early morning) MCT (mean): 3.6-8.3 nmol/l Healthy laboratory worker (age not specified; sample size not specified);
Hungary, UK Adults (age not specified, sample size not specified); country not specified Survey year not specified (Zografos et al., 2010) Abbreviations: /, there was no reference value found for the biomarker of exposure in the mentioned matrix; Ʃ, total; cr., creatinine; GM, geometric mean; MCT, range of measures of central tendency; e.g. mean, median, etc. (Arnold et al., 2013) ; n, sample size; P 90 : 90th percentile; RI: reference interval for clinical guidance; RV 95 , reference value; U/L, units per litre.
Abbreviations of stressor groups and biomarkers are explained in the list of abbreviations at the end of the manuscript.
( # ): Reference limit was "chosen to represent a "healthy" fraction of the general population" (Mocarelli et al., 1986) . ):"no reference value, but should there be analytically reliable and confirmed concentrations of DEDTP in urine above 0.3 mg/l, a special exposure must be expected" (Schulz et al., 2009) .
ƩPYR includes tetramethrin, bifenthrin, λ-cyhalothrin, deltamethrin/ tralomethrin, esfenvalerate/fenvalerate, permethrin and cypermethrin).
:ƩNitrosamines includes NDMA, NSAR, NPRO, NTCA, NMTCA). Table 3 Exposure limit values. phthalates 5oxo -and 5OH-MEHP urine (not further specified) (**) HBM I: 500 µg/l Children (6-13 years), Germany (Schulz et al., 2011) HBM I: 300 µg/l Women in child-bearing age, Germany (Schulz et al., 2011) HBM I: 750 µg/l Adult men and women of the general population (≥14 years) except women in child-bearing age, Germany (Schulz et al., 2011) toxic and potential toxic elements As Cut-off points to distinguish SHS exposed from non-exposed: 2.2 ng/g crea.;
Children (5-11 years), Portugal
Cut-off points to distinguish SHS exposed from non-exposed 2.5 ng/g crea.
Children (5-11 years), Romania
Cut-off points to distinguish SHS exposed from non-exposed: 1.2 ng/g crea.
Non-smoking mothers (27-45 years), Poland
Cut-off points to distinguish SHS exposed from non-exposed: 2.1 ng/g crea.
Non-smoking mothers (26-45 years), Portugal
Cut-off points to distinguish SHS exposed from non-exposed 1.5 ng/g crea. BAT: 600 µg/l Employee (age not specified), Germany (DFG, 2016) Hippuric acid urine (not further specified)
BEI: 1.6 g/g crea.
Employee (age not specified), General population (age not specified), 12 countries (e.g., UK) (Kazlauskaite et al., 2008) cited in (El-Farhan et al., 2017) Abbreviations: ALARP, as low as is reasonably practicable; CC, critical concentration (ANSES, 2013; Aylward et al., 2013) ; OCPs, organochlorine pesticides; PCP, pentachlorophenol. Abbreviations of stressor groups and biomarkers are explained in the list of abbreviations at the end of the manuscript.
(*) The cut-off limit is defined as "eight times the SD [standard deviation] value above the mean" (Mocarelli et al., 1986) .
(**) In the corresponding publications, it is not further specified into first morning urine, spot urine, or 24-h urine. However, the commission findings consistently show no threshold levels especially for developmental toxicity in children. The HBM Commission concluded that establishing an effect threshold for blood lead levels would be arbitrary and therefore not justified (Schulz et al., 2011) . Table 4 Biomonitoring equivalent (BE) values for selected stressors (based on WHO, 2015 and supplemented). N. Steckling et al. Environmental Research 164 (2018) 597-624 * derived by using the urine to blood benzene relationship (Hays et al., 2012) . Abbreviations of stressor groups and biomarkers are explained in the list of abbreviations at the end of the manuscript. Table 5 Opportunities to collect information about the internal exposure of stressors if no specific biomarker of exposure (BoE) is available.
Stressor group Opportunities
Stressor smoking smoking Besides measuring cotinine in human specimens (see Table 2 ) questionnaires are useful to determine internal exposure to smoking. Also, a measurement of expired carbon-monoxide (ECO) is an useful information to determine the internal exposure of smoking (Krautter et al., 2015) . air pollution PM 2.5 , PM 10 Exposure is measurable in terms of mass or number and composition of PM (like specific chemicals, e.g. metals, PAHs) (Karanasiou et al., 2014; Kolosnjaj-Tabi et al., 2015) , however, no specific biomarker is currently available. NO x Products of NO x can be measured in body fluids (Halatek et al., 2005) . NPs
Markers of NPs exposure can range from measurements of specific NPs components, their metabolites, their reaction with cellular macromolecules such as DNA or protein or other effects on cellular processes taken in various bio specimens. ozone Besides 2,3-DHBA (see Table 1 ), biomarkers of oxidative stress (e.g., 8-iso-PGF, 8-OHdG) in blood, urine or other fluids can be useful to identify human ozone exposure; however, the marker are not specific to ozone exposure (Chen et al., 2007; Kadiiska et al., 2013; Ren et al., 2011 ). UFPs noise noise There are no specific markers for noise exposure in the case of nonauditory effects. However, reactions at the organism level can be assessed in terms of effect (immune system, cardiac response). Questionnaires and measurements of the noise level are useful to determine noise exposure. DNA-damaging agents EMF Some non-specific biomarkers are discussed (e.g., hormones), however, they cannot be used as effective markers of exposure. Further research is urgently needed. radon Radon progeny is measurable in blood, hair, and urine, however, not specific. Radon progeny is also a BoE for radium and uranium. Because radon progeny have short half-lives, the time at which the biological sample is taken relevant to time of exposure may be important (Nazaroff and Nero, 1988) . Occupational Hazards biological Besides analyzing the biological agent in body fluids, an occupational exposure can be surveyed by requesting the job history (Nowak, 2010) . A Job-Exposure-Matrix (JEM) can be used to draw conclusions about internal exposure (Pearce and Douwes, 2008) . chemical Besides using BoE for exposure assessment, a JEM is a possibility to identify internal exposure (Pearce and Douwes, 2008) . mechanical A JEM can be used to draw conclusions about internal exposure (Pearce and Douwes, 2008) . physical Physical stressors can be measured in specific units (e.g., hertz for the frequency of vibration (Levy et al., 2011); decibel (dB(A) ) for the noise level (Nowak, 2010) ). Personal dosimetry can measure ionizing radiation (Liljendahl et al., 2013 (Smith et al., 2015) ). The relative importance of measures of socioeconomic status varies with the location of the study so an understanding of local relevant socioeconomic status measures is paramount. In other international studies the availability of similar SES measures may be critical. Furthermore different manifestations of socioeconomic status may be relevant for different health outcomes but other studies have found the strongest relationships between housing tenure and heart disease (Woodward et al., 1992) . For example elsewhere in HEALS we are using car access as a measure of socioeconomic status because it is central to time activity and exposure to air pollution. Such sources often include measures of medical conditions, mental health and wellbeing including self-report, health service records and a few surveys such as national health surveys may include biological samples (Brummett et al., 2013) Note that socioeconomic status itself may not be intrinsically linked to health. Instead it may be a marker for other exposures such as tobacco smoke or poor diet (Giesinger et al., 2014) or poor housing (Gibson et al., 2011) . Furthermore the length of exposure to low SES or low SES in childhood may be more important than current SES for some diseases (Giesinger et al., 2014) . alcohol consumption Acute alcohol consumption can be measured in blood (BAC: blood alcohol content), urine etc. (see Table 2 ). The AUDIT (Alcohol Use Disorders Identification Test) questionnaire can be used to collect data about alcohol consumption (Babor et al., 2001 Biomarkers of physical activity and exercise are the following: Cortisol and testosterone for chronic stress and fatigue; lactate, c(CPK), creatinine, ammonia, lactate dehydrogenase (LDH), uric acid and urea are markers of overtraining; C-reactive protein (CRP), interleukin− 6 (IL−6) and leukocytes are markers of inflammation associated to physical activity (Palacios et al. 2015) . The most used biomarkers to muscle fatigue are cortisol, lactate and IL− 6 and moreover ammonia, leukocytes and oxidative stress parameters are being increasingly used (Palacios et al., 2015) . Reactions of organism are measurable like increased inflammation biomarkers (Margeli et al., 2005) . Global Physical Activity and International Physical Activity Questionnaires (GPAQ and IPAQ) (Craig et al. 2003; Bull et al. 2009 ). consumer products Analytical determination of endocrine disruptors and chemicals of concern contained in consumer products in biological samples are reported in several publications (Faniband et al., 2014) . Use frequency and life style questionnaires. Due the complexity to analyze all the activities, consumer products, and chemicals containing in them, and the different routes of exposures the use of biomarkers of exposure to the chemicals contained in consumer products seems to be a more reasonable way to assess the exposure to this confounder (WHO, 2006) . stress (continued on next page) biomonitoring. Although possible ways of representing the aggregate exposure of some stressors without specific BoEs were found (see Table 5 ), lack of specificity introduces uncertainties in using these to unravel the exposome. As the characteristics of environmental stressors may be very diverse, HBM measurements need to be complemented by tools and technologies that would allow effective HBM data assimilation (Sarigiannis et al., 2014) to accurate relate HBM values to actual human exposure to potential health stressors. This includes an array of technologies, employing environmental monitoring or food item analysis for chemical residuals, or ancillary exposure information retrieved from questionnaires or exposure related databases.
Currently exposure limit values used in chemical safety regulations are derived for the most part on toxicological (i.e. hazard-based) considerations using animal models and extrapolated to human exposure limit values with corrections using assessment factors that pertain to intra-species differences and inter-species variability. Given the cost and the burden to derive such acceptable limit values, they tend to be identified only for a limited number of chemicals and for an even more limited number of primary metabolites. In addition, the lack of harmonization among the various cohort and human biomonitoring studies results in a paucity of widely accepted exposure limit values based on HBM data. Most of these studies are designed to answer specific questions of limited scope, which are mostly related to the quantification of exposure levels among the study participants.
In order to derive exposure limit values, exposure characterization and quantification have to be associated with health observations. In addition, the methods used for interpretation of exposure-to-health associations, including both the statistical methods employed and proper consideration of potential modifiers (genetics, dietary, socioeconomic conditions), are hardly consistent among the studies performed thus far. Several of these issues are addressed in HEALS, and they are to be addressed in the European Human Biomonitoring Initiative (HBM4EU project) (Ganzleben et al., 2017) . Nonetheless, it should be noted that BEs do not address shortcomings in the derivation of current regulatory guidelines. They simply provide estimates of the urinary concentrations corresponding to the regulatory exposure limit as per the respective safety regulation.
Thus, beyond the difficulties in deriving BEs for given exposure reference values, a major problem is the lack of properly defined exposure-based limit and/or reference values. Widespread use of PBBK models will facilitate the derivation of BEs and will support the derivation of more robust associations between external exposures and biomonitoring data. Moreover, this will also allow the use of rapidly produced and inexpensive in vitro reference values, such as the ones derived by US EPA's Toxicity Forecaster (ToxCast) (US EPA, 2016). In this case, for calculating a BE, the starting point will be the biological pathway altering dose (BPAD) instead of an animal based POD. BPAD is analogous to current risk assessment metrics in that it combines doseresponse data with analysis of uncertainty and population variability so as to derive exposure limits (Judson et al., 2010 (Judson et al., , 2011 . The analogy is closest when perturbation of a pathway is a key event in the mode of action (MOA) leading to a specified adverse outcome. An application of this method (use of BPAD for deriving human BE) has been showcased by Sarigiannis et al. (2016) for bisphenol A. Methods for deriving BEs that are based on in vitro systems will allow the faster screening of newly produced chemicals, considering the rapidity, the lower costs and the lack of ethical concerns which occur when animal studies are used to derive PODs.
For EWAS, it is essential to consider a large range of diverse environmental stressors to enable the most complete decoding of the exposome. Relying on only one monitoring method (in this work we refer to biomonitoring) is insufficient. Although analysis of human biosamples for identifying the BoE levels is a good starting point, further elucidation of the individual exposome requires the use of additional molecular analysis such as transcriptomics, metabolomics or adductomics according to the HEALS paradigm; in turn, this requires additional computational tools that have to be used to interpret the biomonitoring and multi-omics results in the frame of a more integrative approach. This is actually one of the key aspects investigated in HEALS.
Limitations and strengths
Despite the amount of information collected in this narrative review, this work has limitations. Information was collected in an expertdriven, distributed, narrative review process which might involve individual researcher decisions. The internal review process reduced this potential researcher bias. The list of stressors included is not exhaustive but evaluated based on the joint opinion of the participating partners as a list of important stressors for the population in the EU. Completeness of the list of stressors is impossible because of the countless number of stressors available and the constant production and release of new (Kingston et al., 2012) . Although a broad range of instruments is available to assess psychological stress, there is no measure that is appropriate for all the aspects of stress (e.g. occupational stress, anxiety, depression, daily hassles, life events, socio-environmental stressors) and for all populations (children, adolescents, adults, pregnant and postpartum women). The exact stress measure that one may choose depends on the question that is being posed (Nast et al., 2013) . Questionnaires/scales are usually validated and their psychometric value is proven but the core challenge is the choice of a proper tool (Kingston et al., 2012) . Exemplary instruments: Perceived Stress Scale (PSS) (Cohen et al., 1983) , State-trait Anxiety Inventory (STA) (Spielberger et al., 1983) , Social Readjustment Rating Scale (Holmes and Rahe, 1967) , APGAR (Adaptation, Partnership, Growth, Affection, Resolve) Family Scale (Smilkstein, 1993; Smilkstein et al., 1982) .
Abbreviations: APGAR, adaptation, partnership, growth, affection, resolve; AUDIT, alcohol use disorders identification Test; BAC, blood alcohol content; CRP, Creactive protein; dB(A), decibel; DNA, deoxyribonucleic acid; ECO, expired carbon-monoxide; EMF, electromagnetic fields; FAS, family affluence scale; FFQ, food frequency questionnaires; GPAQ, global physical activity questionnaires; IL-6, interleukin-6; IMD, index of multiple deprivation; IPAQ, international physical activity questionnaires; JEM, job-exposure-matrix; LDH, lactate dehydrogenase; PSS, perceived stress scale; STA, state-trait anxiety inventory. Abbreviations of stressor groups are explained in the list of abbreviations at the end of the manuscript.
chemicals. This is the case of some substitutes, such as other bisphenols for BPA (e.g. BPF, BPS) (Chen et al., 2016) or non-phthalate plasticizers like DINCH (diisononyl cyclohexane-1,2-dicarboxylate) or DEHT (di(2-ethylhexyl) terephthalate) (Fromme et al., 2016; Larsson et al., 2017) . There are also many other BoE for POPs, including brominated flame retardants such as TBBPA (tetrabromobisphenol A) (Lu et al., 2017) or PBB (polybrominated biphenyls) (Ploteau et al., 2016) . Other examples are organic compounds like glyphosate-based herbicides (Conrad et al., 2017) , carbamates (Haines et al., 2017) ), or micro-as well as macronutrients that have not been included. While vitamin C and folate are included in our work as examples, these and further micronutrients (e.g. iodine or other trace elements, proteins, water or fat soluble vitamins) with health-relevance (e.g., deficiencies) have been discussed previously in another review (Combs et al., 2013) . The lists of reference values, exposure limit values and biomonitoring equivalents were not intended to be complete; rather, examples are listed to provide an inside in the interpretation of data. Presented are rather condensed information and stratifications by age, gender, or other subgroups were not reported. HBM itself contains limitations such as the use of diverse methods for analyses. Also, the derivation of reference and exposure limit values is based on expert decisions usually on the basis of a consensus process. This paper's scope lies in the availability of BoEs and does not include further technical information. For example, it must be kept in mind that the half-life of BoEs is an essential piece of information for the practical use of BoEs. For example, as the biological half-life of nicotine is~2 h (h), cotinine, the major metabolite of nicotine, with a half-life of 17 h, is a more suitable BoE (Benowitz, 1996) . For biomarkers with a half-life of less than 2 h, biomonitoring is not feasible. When the half-life between 2 and 10 h, a sample collected at the end of the day reflects the exposure over the day, while with half-lives of 10-100 h, the optimal sampling time is at the end of the week, and the results reflect exposure during the preceding few days (HSE, 1992) . The half-life of the marker of choice is a key parameter to be taken into account to achieve representative spot sampling results.
In addition the intraclass correlation coefficient (ICC) is important if spot-measurements are intended to estimate long-term exposures. The ICC is a value between 0 and 1 and if the value is close to 0 then repeated measurements of the BoE from the same individual would result in any test result , whereas if the ICC is close to 1 repeated measurements would be very similar (Pleil and Sobus, 2013) .
Also, information about the representativeness of the samples is not included in this paper. For example, the reference values for 3PBA, diethyl phosphate, DMP, DMTP, PCP, PFOA, and PFOS are based on not representative samples of the population in Germany, as underlined by the authors (HBM-UBA, 2003; Heudorf et al., 2006; Schulz et al., 2011) . In contrast, the data from the French National Survey on Nutrition and Health (InVS, 2010) and the German Environmental Survey on Children (Schulz et al., 2012) as well as the reference values for PBDEs (Gari and Grimalt, 2013) and β-HCH (Gari et al., 2014) were derived based on representative samples.
If no other reference value (e.g., RV 95 ) was available, information was included on measures of central tendency (MCT). In several cases, the presented MCTs represent arithmetic mean, geometric mean, median, or a mixture of them. It needs to be mentioned, that the mean (arithmetic mean, average) should be avoided in HBM studies, since the distribution of the values do not follow a normal distribution. Thus, mean values do not represent the central tendency.
Strengths of this work are the broad inclusion of diverse environmental stressors, the extensive list of BoEs and corresponding reference values, exposure limit values and biomonitoring equivalents as well as the inclusion of possibilities to measure the internal exposure of stressors without specific BoE.
Conclusions
Given the diversity of environmental stressors that need to be examined to unravel the exposome, current-day human biomonitoring is suitable for determining the internal exposome of several stressors (e.g., metals, PCBs, VOCs) but not for many others (e.g., NO x , PM, physical activity). Most chemical and biological stressors are measureable in human specimens whereas exposure to the majority of physical, social and psychological stressors needs to be assessed using methods complementary to HBM. The joint and harmonized application of methods and tools to unravel the exposome represents the main task of the HEALS project.
